EP 1294756 A2 20030326 - BIOSYNTHETIC ONCOLYTIC MOLECULES AND USES THEREFOR
Title (en)
BIOSYNTHETIC ONCOLYTIC MOLECULES AND USES THEREFOR
Title (de)
BIOSYNTHETISCHE ONCOLYTISCHE MOLEKULE UND DEREN VERWENDUNG
Title (fr)
MOLECULES ONCOLYTIQUES BIOSYNTHETIQUES ET LEUR UTILISATION
Publication
Application
Priority
- US 0119239 W 20010613
- US 21143600 P 20000613
Abstract (en)
[origin: WO0196395A2] Novel biosynthetic oncolytic molecules are provided. The biosynthetic oncolytic molecules include functional domains derived from osteopontin. Preferred biosynthetic oncolytic molecules include an apoptotic domain derived from osteopontin. The oncolytic molecules of the present invention are capable of promoting cellular apoptosis. Accordingly, therapeutic uses are disclosed which feature the biosynthetic oncolytic molecules of the present invention.
IPC 1-7
IPC 8 full level
A61P 35/00 (2006.01); C07K 14/52 (2006.01); C12N 15/19 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP KR)
A61P 35/00 (2017.12 - EP); C07K 14/52 (2013.01 - EP KR); A61K 38/00 (2013.01 - EP); C07K 2319/00 (2013.01 - EP); C07K 2319/02 (2013.01 - EP); C12N 2799/027 (2013.01 - EP)
Citation (search report)
See references of WO 0196395A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0196395 A2 20011220; WO 0196395 A3 20020516; AU 6694701 A 20011224; BR 0111628 A 20040720; CA 2411346 A1 20011220; CN 1439020 A 20030827; EP 1294756 A2 20030326; IL 153206 A0 20030706; KR 20030009522 A 20030129; ZA 200300197 B 20040310
DOCDB simple family (application)
US 0119239 W 20010613; AU 6694701 A 20010613; BR 0111628 A 20010613; CA 2411346 A 20010613; CN 01811084 A 20010613; EP 01944549 A 20010613; IL 15320601 A 20010613; KR 20027016941 A 20021212; ZA 200300197 A 20030108